Natixis Advisors LLC cut its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 26.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 108,177 shares of the industrial products company's stock after selling 38,292 shares during the period. Natixis Advisors LLC's holdings in Xylem were worth $14,607,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. City Holding Co. raised its holdings in Xylem by 3.8% in the 3rd quarter. City Holding Co. now owns 2,071 shares of the industrial products company's stock valued at $280,000 after acquiring an additional 75 shares in the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Xylem by 68.8% in the 1st quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company's stock worth $25,000 after buying an additional 77 shares in the last quarter. First Trust Direct Indexing L.P. raised its holdings in shares of Xylem by 0.9% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 9,070 shares of the industrial products company's stock worth $1,225,000 after buying an additional 78 shares in the last quarter. Addison Advisors LLC raised its holdings in shares of Xylem by 5.8% in the 2nd quarter. Addison Advisors LLC now owns 1,486 shares of the industrial products company's stock worth $202,000 after buying an additional 82 shares in the last quarter. Finally, Bangor Savings Bank raised its holdings in shares of Xylem by 56.7% in the 3rd quarter. Bangor Savings Bank now owns 235 shares of the industrial products company's stock worth $32,000 after buying an additional 85 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
XYL has been the subject of a number of recent analyst reports. TD Cowen dropped their price target on Xylem from $138.00 to $125.00 and set a "hold" rating for the company in a report on Wednesday, November 6th. Robert W. Baird decreased their price objective on Xylem from $175.00 to $154.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Stifel Nicolaus increased their price objective on Xylem from $170.00 to $172.00 and gave the company a "buy" rating in a research report on Wednesday, July 31st. UBS Group initiated coverage on Xylem in a research report on Tuesday, August 13th. They issued a "buy" rating and a $165.00 price objective on the stock. Finally, Royal Bank of Canada reduced their price target on Xylem from $163.00 to $162.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $147.17.
View Our Latest Stock Analysis on XYL
Xylem Stock Performance
Shares of NYSE:XYL traded down $0.23 during mid-day trading on Wednesday, reaching $122.00. The company had a trading volume of 508,407 shares, compared to its average volume of 1,208,942. The company has a current ratio of 1.96, a quick ratio of 1.42 and a debt-to-equity ratio of 0.19. The firm has a market cap of $29.64 billion, a price-to-earnings ratio of 35.73, a PEG ratio of 2.25 and a beta of 1.05. The company's 50-day moving average price is $130.47 and its 200-day moving average price is $134.54. Xylem Inc. has a one year low of $100.46 and a one year high of $146.08.
Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings data on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, meeting analysts' consensus estimates of $1.11. The business had revenue of $2.10 billion during the quarter, compared to analyst estimates of $2.17 billion. Xylem had a net margin of 9.85% and a return on equity of 9.61%. Xylem's revenue was up .2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.99 EPS. As a group, equities research analysts anticipate that Xylem Inc. will post 4.23 EPS for the current fiscal year.
Xylem Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 24th. Shareholders of record on Tuesday, November 26th will be paid a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 1.18%. The ex-dividend date of this dividend is Tuesday, November 26th. Xylem's dividend payout ratio is presently 42.11%.
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Read More
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.